Posts Tagged ‘ABUS’

World Market in Breast Imaging

Posted on: October 11th, 2019 by admin No Comments

Signify Research, based in the United Kingdom, has recently published an important market research report entitled “Breast Imaging – World […]

Ultrasound Screening after FFDM and DBT

Posted on: October 4th, 2019 by admin No Comments

In the past decade, 38 states in the USA have enacted legislation requiring radiologists to notify a woman if, after undergoing a […]

Celebrating MEP@40

Posted on: September 27th, 2019 by admin 1 Comment

In 1979, the Journal of Biomedical Engineering was launched and fifteen years later, in 1994, the journal was renamed Medical […]

DBT in the News Again

Posted on: August 23rd, 2019 by admin 1 Comment

Digital breast tomosynthesis (DBT), commonly known as 3D mammography, has recently been the focus of two research articles from Norway. […]

Giving Back

Posted on: July 26th, 2019 by admin

Two women whose breast cancer was missed during routine annual mammograms combined forces four years ago to launch the educational […]

HHUS versus ABUS

Posted on: July 19th, 2019 by admin 2 Comments

Fifteen years ago, Peter Dempsey wrote a fascinating article on the history of breast ultrasound that appeared in the Journal […]

Health Tech Hub of Africa

Posted on: June 28th, 2019 by admin 1 Comment

Among the strategic projects of Wesgro – a local trade and investment agency – are included Air Access, to develop […]

Launch of a New Journal

Posted on: May 24th, 2019 by admin 1 Comment

The Society of Breast Imaging and Oxford University Press have recently launched the Journal of Breast Imaging (JBI), the first peer-reviewed journal […]

ABUS vs DBT – Again

Posted on: March 8th, 2019 by admin 2 Comments

The European Congress of Radiology, with a giant octopus in the registration area and a collage of aquatic images, concluded in […]

QT Ultrasound Launches Imaging Centres

Posted on: January 18th, 2019 by admin 2 Comments

Five years ago, Delphinus announced it had received 510(k) clearance from the FDA and was able to begin marketing its whole breast […]